NCT03280043View on ClinicalTrials.gov

Risk of Hematoma After Ketorolac Use in Reduction Mammoplasty.

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

May 20, 2017

Study Completion Date

August 20, 2017

Conditions
Breast ReductionReduction MammoplastyHematomaHemorrhage
Interventions
PROCEDURE

Hematoma

Hematoma requiring return to operating room.

Trial Locations (2)

L8N 3Z5

St. Joseph's Healthcare Hamilton, Hamilton

L8N3Z5

Hamilton Health Sciences, Hamilton

All Listed Sponsors
lead

McMaster University

OTHER

NCT03280043 - Risk of Hematoma After Ketorolac Use in Reduction Mammoplasty. | Biotech Hunter | Biotech Hunter